Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Research Communications in Molecular Pathology and Pharmacology|September 8, 1998
Investigation of the molecular changes during chemotherapy in non-Hodgkin's lymphomaH Yazici, P Saip, S Inanç, et al.
Genetics and Molecular Research : GMR|January 23, 2010
Mammaglobin and maspin transcripts in blood may reflect disease progression and the effect of therapy in breast cancerO Bitisik, P Saip, S Saglam, et al.
American Journal of Clinical Oncology|July 28, 2001
Stevens-Johnson syndrome in a patient receiving anticonvulsant therapy during cranial irradiationY Eralp, A Aydiner, F Taş, et al.
Acta Oncologica (Stockholm, Sweden)|February 9, 2000
Factors influencing the distribution of metastases and survival in extensive disease small cell lung cancerF Tas, A Aydiner, E Topuz, et al.
Clinical Biochemistry|March 13, 1999
Bcl-2 gene rearrangements and apoptosis rates in patients with non-Hodgkin's lymphoma during chemotherapyH Yazici, L Yalcinkaya, S Inanc, et al.
European Journal of Gynaecological Oncology|June 26, 1998
Intraperitoneal cisplatin-mitoxantrone and intravenous ifosfamide combination as first-line treatment of ovarian cancerE Topuz, P Saip, A Aydmer, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 30, 2001
Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancerF Tas, A Aydiner, E Topuz, et al.
European Journal of Gynaecological Oncology|June 17, 2003
Efficacy of cisplatin and cyclophosphamide combination for recurrent and metastatic carcinoma of the uterine cervixY Eralp, P Saip, B Sakar, et al.
European Journal of Gynaecological Oncology|June 26, 1998
Catheter complications associated with intraperitoneal chemotherapyE Topuz, P Saip, A Aydiner, et al.
Pageof 3